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ASSESSMENT AND VISUALIZATION OF NEURONAL REMODELING IN 
ASSOCIATION WITH VARIOUS CARDIOVASCULAR CONDITIONS 
AMANDA G. ARAUJO 
ABSTRACT 
It has been reported in previous works that there is a greater neuron density in the 
stellate ganglion of patients with cardiovascular disease. However, an analysis of this 
effect on neuron density and how it may differ between the different conditions falling 
under the realm of cardiovascular disease has yet to be studied.  
Analysis of this relationship between the Autonomic Nervous System (ANS) and 
cardiovascular function can provide insight into the disease process of each of the studied 
conditions, and more specifically, whether the ANS plays more of a causative or 
compensatory role in these instances. In this study, stellate ganglion pathology from 
patients with Coronary Artery Disease (CAD), Myocardial Infarction (MI), or Heart 
Failure (HF) were studied and compared to subjects with little to no cardiovascular 
pathology. We hypothesized that cardiovascular disease patients would have higher 
levels of neural remodeling, and perhaps more so in chronic conditions like CAD and HF 
as opposed to single events like MI.  
Stellate ganglia were harvested from one or both sides of 17 human cadavers and 
prepared slides from the middle section of each ganglion were scanned digitally for 
analysis. Neurons were counted using an automated algorithm accounting for size and 
shape to specifically select for nerve cell bodies, and for further analysis, heat maps of 
neuron nearest neighbor density were created.  
 vi 
Analysis considering the variables of neuron size, number of neurons, and percent 
area of the ganglion occupied by neurons resulted in a statistical main effect of disease 
cohort but not side of the ganglion or the interaction of cohort and side. Between subject 
effects showed that only average neuron size was a significant factor in the model.  
Overall, patients with cardiovascular disease displayed neural remodeling in 
comparison to those with little to no cardiovascular pathology, and these effects were 
different across the several different conditions. Some caveats to this study were sample 
size, especially for MI patients, and analysis of only the middle section of each ganglion. 
A further analysis including more of the ganglion outside of a representative section, and 
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According to the Centers for Disease Control and Prevention, heart disease is the leading 
cause of death in both sexes and across people of most racial and ethnic groups, so much 
so that it’s been reported that one person in the United States dies of cardiovascular disease 
every 37 seconds. The reason for such a high prevalence of cardiovascular disease is due 
to the key risk factors, including high blood pressure, high cholesterol and smoking, being 
very common among this country’s population. In fact, it’s been approximated that 47% 
of the US population have at least one of the three main key factors.5 This startling statistic 
goes without consideration of other risk factors such as diabetes, obesity, unhealthy diet, 
sedentary lifestyle and alcohol use, all of which also have a high prevalence in the US. 
Therefore, it is imperative that there be a focus on cardiovascular disease in medical 
research to discover more about the causes of cardiovascular disease and what contributes 
to its progression.  
 
In addition to the risk factors discussed above, there has also been focus on what intrinsic 
factors play a role in heart function, and furthermore, the development of pathology. It has 
been reported that the cardiovascular system is controlled by a combined effort of the 
heart’s unique conduction system, the Autonomic Nervous System (ANS), as well as the 
endocrine system.11 Attention to the influence of the ANS on heart function has been 
brought to the forefront due to the two system’s extensive anatomic relationship. The two 
systems function reciprocally by innervation of ANS nerve fibers in cardiac pacemaker 
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tissue to modulate heart rate and conduction velocity, in addition to similar innervation of 
atrial and ventricular cardiomyocytes to influence the force of contraction and relaxation.14 
This constant communication between the cardiovascular system and ANS is important for 
influencing adjustments in heart function.  
 
The ANS is responsible for regulating the unconscious actions of the body, such as heart 
rate, respiratory rate, among other functions. This regulation is present under all 
circumstances whether the body be in normal conditions, or under stress, through its 
balance of the parasympathetic and sympathetic divisions. The parasympathetic nervous 
system (PNS) unconsciously acts to conserve energy when resting or recuperating from a 
harmful event, whereas the sympathetic nervous system (SNS) responds to harmful events 
or stimuli by an increase in activity as a compensatory mechanism. Nerve fibers from both 
divisions of the ANS innervate structures all throughout the body that act to maintain a 
crucial balance, or homeostasis, of the body’s unconscious actions.  
 
As described previously, a major structure innervated by the ANS is the heart, in which 
homeostasis is maintained through a combination of sympathetic and parasympathetic 
nerves branching from the cardiac plexus, which lies between the aortic arch and 
pulmonary trunk. These nerves extend out to the coronary arteries and branch further to 
distribute nerve function to the atrium and surrounding vessels/organs.20 However some 
structures, such as most blood vessels, are not parasympathetically innervated and therefore 
do not respond to parasympathetic stimulation. Thus, many characteristics, such as 
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diameter of these vessels, are mediated largely by the sympathetic division.11 The idea has 
been supported that the ANS plays a major role in the regulation of cardiovascular function 
at all levels, whether in a state of resting or exposed to stimuli that induce increased or 
decreased heart function.24  
 
Special attention has been directed towards the SNS in particular over the last few decades 
for its role in cardiovascular disease. Stimulating the SNS yields responses including pupil 
dilatation, bronchiole dilatation, blood vessel constriction, inhibition of peristalsis and 
increased renin secretion of the kidneys, some of which undoubtedly play a role in 
cardiovascular function.11 When encountering a stimulus that hinders any unconscious 
actions of the body, such as something that would inhibit or exacerbate cardiovascular 
function, it is expected that the ANS will adjust appropriately. With knowledge of the role 
the ANS plays in these events, there is speculation about whether these adjustments in 
function can be histologically observable within structures of the ANS. 
 
The cervicothoracic ganglion (CTG), also known as the stellate ganglion, is a collection of 
sympathetic nerve nuclei and fibers formed by the fusion of the inferior cervical, and first 
thoracic ganglia.29 The stellate ganglion is known as the main sympathetic input into the 
heart and, in particular, is known to house cardiac autonomic nerves, which are associated 
in cardiac plexuses and pacemaker regions.4,14 These cardiac autonomic nerves are 
sensitive to signaling molecules, which will induce either a more sympathetic influence on 
heart function, or allow a more parasympathetic influence (via the vagus nerve). The 
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imbalance of these two divisions of the ANS is associated with cardiac pathology 
development and progression of cardiac pathology.6,14 Excessive sympathetic activity, 
causing an ANS imbalance, and/or aberrant nerve remodeling are becoming recognized 
features of the pathogenesis of several different cardiovascular diseases.14 Two molecules 
in particular that have been associated with nerve sprouting are GAP-43 and Nerve Growth 
Factor (NGF) which have been shown to increase early in organisms with myocardial 
infarction (MI) as well as in left stellate ganglion stimulation in dogs.1,3,26,27,37 It has been 
proposed that once an increase in NGF is present, whether pathologically or 
experimentally, nerve sprouting will occur, which will enhance the SNS influence on heart 
function. This idea has been supported by studies showing that both an infusion of NGF 
and stimulation of the left stellate ganglion are associated with an increase in ventricular 
tachycardia (VT) in patients with or without MI.3,32   
 
In addition to the above experiments stimulating the stellate ganglion, several experiments 
blocking one or both of the stellate ganglion have also been performed. In individuals 
without signs of cardiovascular disease, left stellate ganglion block had no significant 
effect, but blockage of the right stellate ganglia resulted in a decrease in heart rate variation 
(HRV).10,19 With both stellate ganglia blocked, there was shown to be a decrease in both 
HRV and spontaneous cardiac baroreflex sensitivity, but these results are still considered 




Assessment of nerve activity has also been studied in association with MI and stellate 
ganglion blocks. Stellate ganglion nerve activity (SGNA) was shown to be increased at 24-
hours post-MI and these levels remained elevated for up to 8 weeks. In addition, previous 
studies have demonstrated a significant correlation between the SGNA and HRV.13 
However, in heart failure, this correlation is found to be weakened due to SA node 
dysfunction.29 Furthermore, the cardiac sympathetic nerve activity (CSNA) was also shown 
to increase just one-hour post-MI; this elevation of the CSNA persisted for about one 
week.17 An increase in the number of cell bodies has also been noted in the left stellate 
ganglia in the presence of fibrosis, hyper-sympathetic stimulation and MI.35 Previous 
studies have shown that there is a change in nerve activity as a result of acute cardiac 
problems, such as MI, but this is less well understood in more prolonged conditions such 
as coronary artery disease (CAD) and heart failure (HF).  
 
In HF, studies have reported a sympathetic activation subsequent to disease onset that 
adversely impacts the clinical outcome.28 Where HF appears to differ from other 
cardiovascular diseases in its relationship to the ANS is in the reuptake of norepinephrine 
(NE), which is the main neurotransmitter of the SNS.8 HF is not only associated with a 
sympathetically mediated increase in the release of NE but also a decrease in the efficiency 
of NE reuptake and storage, resulting in a further increase in adrenergic drive.8,22 The 
mechanism of increased SNS activity in HF has been shown throughout the literature to 
also occur in MI, as well as in sudden cardiac death, but the literature has not provided 




As described later in the disease classifications examined in this study, CAD can lead to 
both MI and HF, although development of these cardiac pathologies is mutually inclusive, 
they do not always develop in patients with CAD. Furthermore, the development of HF or 
a MI is multifactorial and can be furthermore be completely unrelated to CAD.37 Therefore, 
it is of interest to observe the histological changes in SNS structures, that are indicative of 
alterations in SNS activity in the setting of all the aforementioned cardiovascular 
conditions both independently and in cases where these conditions overlap. 
 
It is current practice according to the National Heart, Lung and Blood Institute to diagnose 
MI, CAD, and HF by combinations of blood tests, stress tests,  chest x-rays and 
electrocardiograms (EKG). CAD can also be diagnosed using tests such as coronary 
calcium scans, cardiac positron emission tomography (PET) scans, and cardiac magnetic 
resonance imaging (MRI), while HF can be diagnosed utilizing thyroid function tests, 
Doppler ultrasound, halter monitors, as well as cardiac MRIs.33 Thus, there is a plethora of 
testing involved in making a cardiovascular disease diagnosis, although not all tests are 
performed in all cases. Given previous research, it could be possible that SNS activity could 
be added to the list of diagnostic testing for cardiovascular disease, and furthermore, that 
this activity can be a therapeutic target for treatment and stabilization of these conditions.  
 
The purpose of this study was to examine stellate ganglion samples from patients with 
several different types of cardiovascular disease, namely HF, MI, and CAD, and compare 
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them to healthy controls to assess if these cardiac pathologies are associated with any 






Previous work by members of the laboratory and collaborators showed neuronal 
hypertrophy in association with chronic cardiomyopathy, but the results warranted further 
investigation to determine the implications of these histological observations. Literature 
review was a big part of expanding this research, as the relationship between the 
cardiovascular system and ANS was explored extensively before determining an exact 
direction to take research in. Upon deeper understanding of this relationship between the 
two systems, literature search was directed towards cardiovascular pathology in relation 
to the ANS. It was discovered that a lot of research was published on MI and its 
relationship with the ANS, but not as much was found on conditions such as HF and 
CAD.  After literature review, it was determined that it would be of interest to investigate 




Whole left and right stellate ganglions were collected from human cadavers utilized as 
opportunity samples. Use of preserved human specimens was in accordance with 
institutional guidelines. All available information on medical history and/or surgical 
intervention, without individual identifiable information of the cadavers was collected.  
The excisions were completed carefully, as the ganglia are regarded as quite difficult to 
locate, as they lie nestled between the vertebral and carotid arteries of either side of the 
 
9 
neck. Ganglia were preserved immediately after retrieval, marked for supero-inferior 
orientation and sectioned for histological analyses.  
 
Classification 
Table 1 shows characteristics of the cadaveric subjects included in this study for a total of 
15 subjects with both stellate ganglia obtained from each subject, for a total of 30 ganglia 
analyzed. Based on cardiac pathology present upon observation, subjects were classified 
into five disease categories, (1) little to no notable cardiovascular pathology (NO), (2) 
Myocardial Infarction (MI), (3) Heart Failure (HF), (4) mild Coronary Artery Disease 
(CAD), and (5) clinically-significant CAD, also reported in Table 1 with the clinical 
observations. We used the following operational definitions of the pathological conditions 
below. 
 
Myocardial Infarction (MI)  
The U.S. National Library of Medicine defines a Myocardial Infarction (MI), or heart 
attack, as a sudden blockage of blood flow to the heart. This blockage inhibits oxygen from 
reaching the heart and the muscle tissue will begin to die in infarcted region(s). Extent of 
damage to the heart is influenced by the size of the area affected by the blockage and time 
elapsed before treatment.25 In healing, the heart will form scar tissue, which cannot contract 
as the normal tissue, that can cause further cardiac issues down the line. MI is identified in 
post-mortem examination by patches of scar tissue left as remnants of the injury.  
Heart Failure (HF) 
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Heart Failure is defined by the U.S. National Library of Medicine as a general condition in 
which the heart cannot pump enough blood in the proper way to meet the needs of the 
body. This condition can be a complication of CAD, MI, high blood pressure 
(hypertension) or diabetes and is more common in men.25 Fibrosis of the cardiac tissue is 
a grossly-observable feature of this disease process among other clinical observations such 
as edema of the limbs. 
 
Coronary Artery Disease (CAD) 
According to the U.S. National Library of Medicine, CAD is caused by the hardening and 
narrowing of arteries that supply blood to the heart by a buildup of cholesterol and plaque 
on the vessel walls. As the disease progresses, less blood and oxygen can be delivered to 
the heart and can lead to a MI and/or HF.25 CAD is identified grossly by calcification or 
plaque buildup in the coronary arteries, or even by grafts in vessels indicative of a graft 
procedure to promote blood flow. 
 
Mild Coronary Artery Disease (CAD) 
Using the same definition of CAD from the U.S. National Library of Medicine, mild CAD 
was characterized and identified grossly by mild calcification or plaque buildup of the 
coronary arteries, unaccompanied by grafts in the vessel or a confirmed CAD diagnosis in 





Table 1. Classification of Subjects into Cardiovascular Disease Cohorts  
Table outlining subjects observed in this study with clinical observations to corroborate the 
assigned disease group assigned in this study. CA, Coronary Artery; CAD, Coronary 
Artery Disease; RCA, Right Coronary Artery; LAD, left anterior descending; PDA, Patent 
ductus arteriosus. 
 
Disease Category Clinical Observations 
No cardio-path Normal looking – minimal fibrosis noted. 
No cardio-path Normal looking – minimal fibrosis, perhaps age assoc. 
No cardio-path Normal looking- no evidence of infarct or fibrosis. 
MI Lateral wall infarction – PDA disease* 
HF Very large heart, aortic endograft, severe fibrosis. 
HF Right atrial/ventricle enlargement, mitral valve 
abnormalities, interstitial fibrosis, calcification but no 
atherosclerosis. 
HF Replacement fibrosis, amyloid in vessels, thick vessels. 
HF Interstitial/perivascular fibrosis, focal myocarditis.  
HF Widespread interstitial and perivascular fibrosis.  
Mild CAD Coronary Artery Bypass Graft – CAD not extensive. 
Mild CAD Calcified left anterior descending (LAD) coronary artery. 
Mild CAD Left main CA calcification – hypertension likely. 
CAD CAD known, RCA bypass graft – no indication of MI. 
CAD RCA and likely LAD grafts, aortic valve replacement. 





Tissue Preparation and Histological Studies 
Gross anatomical identification and histopathology were the main practices in this study, 
as they are the mainstays of cardiovascular pathology practice.2 Stellate ganglia were 
harvested and preserved in formalin prior to being embedded in paraffin, then serially 
sectioned in the coronal plane (10 µm). The ganglia were stained with luxol fast blue and 
cresyl violet for visualization of white matter and neurons. Prepared slides from the 
approximated middle section of each ganglion were scanned digitally using Aperio Scan 
Scope System (Vista CA). The neurons were segmented using an automated algorithm 
developed using ImageJ, which selected nerve cell bodies using characteristics such as size, 
circularity and depth of stain retention. Output from this program included an image 
outlining all positive areas, or neurons, found using the algorithm as well as raw data 
including average cell size, in pixels, the cell number count as well as percent area occupied 




























Figure 1. Segmentation of Neurons in Stellate Ganglia Using ImageJ 
Original histology image(a) input into ImageJ, resultant outline output(b) and highlights of 
the raw data(c). 
 
 
Heat Map Generation and Scoring 
Heat maps of neuron nearest neighbor density were created by convolving the centroid 
location for each neuron weighted by its area with a linear function, f(r), where r is the 
radial distance from the neuron centroid as a fraction of the maximum image dimension, 
shown below: 
  	 1 	 
 , 	  
0,   
Clustering is scored using a colored scale on the side of maps with values associated 





clustering, 3-6 is considered moderate and 6-9 is considered heavy clustering. Samples 
with corresponding heat maps that have coloration between these set ranges were scored 
to reflect this, i.e. moderate-heavy.  
 
QUANTIFICATION AND STATISTICAL ANALYSIS 
A MANOVA was performed using SPSS to test the effect of heart condition type on 
variables of neural remodeling including cell size, cell count, and percent (%) area 
occupied by neurons in the entire ganglia. A two-way MANOVA model was used for 
analysis given the categorical, independent variables of disease cohort was being compared 





Neuronal Cell Count and Percent Area Occupied Show No Association with Disease 
The neuronal cell count and the percent area of the total ganglion occupied by these neurons 
are reported in Table 2. The cell count was highly variable, and an increase in the neuronal 
cell count was not associated with any of the three cardiovascular conditions. In fact, one 
subject with no cardiovascular pathology had a higher neuron count in both ganglion than 
a subject in this study who was diagnosed with CAD. There was, in addition, no 
consistency in the number of neurons present in the ganglion on the ipsilateral versus 
contralateral side of the body affected by cardiovascular pathology, as there were several 
instances of the affected side’s ganglion having fewer neurons than in the contralateral 
ganglion. 
 
Similarly, the percent area occupied with neurons in the ganglion also did not correlate 
with the side of the pathology. In some cases, such as in one of our CAD subjects who had 
left-sided pathology, there was a higher percent occupied by neurons in the left ganglion 
than in the right. However, in two subjects who also had left-sided pathology, but were 
diagnosed with HF and MI, the percent area of the ganglion occupied by neurons was 
higher in the right ganglion. In summary, there was no statistically significant correlation 
between either the neuronal cell count or percent area occupied by neurons in any of the 





Table 2. Neuron Size, Number and Area Values for All Samples  
Table reporting average cell count over both ganglia in each subject as well as number of 
cells and % area occupied by neuron cell bodies in the ganglia for each side. Pathology 
side and cohort were included to assess agreement between side impacted by pathology 
and the ganglion on that side of the body. 
 
Cohort Average Cell 
Size (pixels) 
# of cells L/R % area L/R Left or Right 
Pathology? 
NO 542.75 2195 / 1880 1.86% / 2.84% N/A 
NO 442.00 2110 / 1206 1.46% / 2.29% N/A 
NO 450.32 428 / 826 0.91% / 1.45% N/A 
MI 639.54 1545 / 2561 3.14% / 4.10% Left 
HF 568.96 2862 / 3522 3.20% / 2.81% Both 
HF 579.21 1962 / 1354 1.14% / 2.86% Left 
HF 459.17 1174 / 505 0.73% / 0.45% N/A 
HF 455.75 1677 / 1129 0.97% / 1.13% Right 
HF 565.80 1054 / 1908 2.50% / 1.52% N/A 
Mild CAD  501.99 3842 / 1660 2.74% / 1.33% Left 
Mild CAD  544.52 1361 / 2846 1.37% / 3.62% Both – Left more 
Mild CAD 513.76 3320 / 784 2.37% / 1.81% Left 
CAD 632.78 619 / 1045 4.99% / 3.00% Both 
CAD 584.68 3478 / 3093 2.03% / 1.83% Both 





Neuronal Size Offers Insight on Cardiovascular Health 
Both MI and CAD patients in this study had larger neurons in their stellate ganglia and this 
was shown to be statistically significant in comparison to no cardiovascular pathology 
(P=0.011, P=0.004, respectively). HF and mild CAD patients displayed slightly enlarged 
neurons in comparison to no pathology, but these differences were not shown to be 
statistically significant. Interestingly, the difference in cell size between CAD patients and 
HF patients was on a trend towards significance (P=0.063).  
 
Figure 2. Neuronal Size Offers Insight on Cardiovascular Health 
Quantification of mean neuronal size in each of the respective disease populations. 
Differences signified by (**) are statistically significant (p<0.05); difference signified by 








Clustering of Neurons Differs Between Disease Cohorts 
The generation of density maps for every ganglion, shown in Figure 2, allowed for 
visualization of the distribution of neurons in each sample. Both CAD and HF showed 
higher levels of clustering, as evidence by the orange and yellow colored areas present on 
their density maps, which are indicative of higher concentrations of neurons in those areas. 
Subjects with mild CAD showed these same colored areas, but not to the same effect as 
CAD and HF. Those with little to no cardiovascular pathology showed very minimal 


















Figure 3. Clustering of Neurons Differs Between Disease Cohorts:  
Heat maps of neuron nearest neighbor density for representative samples from the same 
subject in each respective cohort. Maps were created by convolving centroid location for 
each neuron weighted by its area with a linear function, f(r), where r is the radial distance 
from the neuron centroid as a fraction of the maximum image dimension and f(r) = (1-5r) 
for r < 0.2 and 0 otherwise. Maps are labeled by cohort, and each image follows the same 
layout: (a) histology of left ganglion, (b) heat map of left ganglion, (c) histology of right 














Table 3. Heat Map Observations for All Samples 
Table reporting the observations of heat maps which assessed the extent of clustering on 










Table 3. Heat Map Observations for All Samples 
Table reporting the observations of heat maps which assessed the extent of clustering on 








clustering Left SG Right SG 
NO None – minimal None – minimal N/A Dispersed 
throughout structure. 
NO Moderate Moderate N/A Left dispersed 
throughout 
Right concentrates at 
inferior pole 
NO None – minimal None – minimal N/A Dispersed 
throughout structure. 
MI Minimal Minimal - moderate Left Concentrated at 
superior pole 
HF Minimal - moderate Moderate N/A Dispersed 
throughout structure. 
HF Minimal None-minimal Right Dispersed 
throughout structure. 
HF Moderate Moderate - heavy Both Left dispersed 
throughout 
Right concentrated 
HF Minimal Minimal Left Dispersed 
throughout structure. 


























CAD Moderate Moderate – heavy Both Concentrated at 
inferior pole 
















In general, neural remodeling was observed in all cardiovascular diseases studied in 
comparison to subjects with very little to no cardiovascular pathology present. The most 
compelling type of neural remodeling in this study was the statistically significant 
enlargement of neurons in both CAD and MI patients in comparison to normal neuronal 
size in healthy control patients, as well as CAD neurons being on a trend towards statistical 
significance of enlargement to neurons in HF subjects. However, it was observed that these 
differences in neuronal size did not appear to correlate with the corresponding heat maps 
generated. Although minor differences were present, there was no pattern or statistically 
significant differences in neuron number and percent area of ganglion occupied by neurons 
across all the cardiovascular diseases studied and the control group. The variance seen 
across all the groups emphasizes the distinctive impact of the ANS on these different 
cardiovascular diseases.  
 
Differences in Cardiac Pathology Disease Progression 
Previous studies have investigated the role of the ANS in a variety of cardiovascular 
pathologies and have reported that sympathetic activation occurs subsequent to the onset 
of HF, adversely impacting the clinical outcome. Other conditions, such as essential 
hypertension, require sympathetic activation for initiation and maintenance of the 
condition.27 This makes sense in the setting of hypertension, as increased sympathetic 
stimulation would cause increased vascular tone resulting in the increase in blood pressure 
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which encompasses hypertension. However, this sympathetic activation would be more of 
a compensatory, rather than a causative, mechanism in HF, where blood flow is not meeting 
the needs of the body. In these cases, when the blood flow cannot adequately supply the 
body, sympathetic activation is crucial to release more NE to send the message to the heart 
to increase its rate as a way to pump blood out faster to try to meet the body’s needs. 
Similarly, in CAD this sympathetic activation would be necessary to increase the function 
of the heart as required to adequately pump blood through the vessels, now narrowed as a 
result of obstruction by plaques from the condition. The plaque build-ups leading to CAD 
are associated with many factors such as poor diet, sedentary lifestyles, smoking, genetic 
predispositions and this can become even further complicated by comorbidities such as 
high blood pressure or diabetes. Therefore, CAD may also have cases where sympathetic 
activity was increased prior to disease onset, due to confounding comorbidities such as 
hypertension, in contrast to the pattern of sympathetic activation observed in HF. Prior to 
performing this study, we hypothesized that HF and CAD would demonstrate similar in 
histopathology, as they are both prolonged conditions, whereas an acute condition like MI 
would demonstrate a different, or less extensive, pattern.  
 
Contrary to what we predicted, our histological analysis showed greater neuron 
enlargement in the CAD cohort than the HF cohort, and CAD neurons were on a trend to 
being statistically significantly larger than neurons from the HF subjects. Perhaps, the CAD 
cases observed were more severe than the HF cases, or had confounding conditions causing 
higher degrees of growth in these sympathetic neurons, presumably a result of the induction 
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of higher SNS activity or influence. However, both HF and CAD cohorts showed clustering 
of neurons within the ganglia, which we are interpreting as perhaps evidence of nerve 
sprouting, in which new neurons were sprouted from existing neurons to meet higher needs 
of the ANS. This similarity in clustering patterns supports the original prediction of similar 
histopathology between CAD and HF, which are both prolonged conditions of the body. 
Where these similarities digress is in the observations of CAD patients displaying 
clustering to a higher degree than HF, paralleled by the trend towards significant difference 
in neuron size between the two cohorts. Thus, the CAD cohort had the greatest histological 
findings overall, alluding to perhaps a higher degree of influence on, or compensatory 
mechanism to this condition by the SNS. While CAD can also be a precursor for HF, the 
two diseases still prove to have differences in their histological findings, which alludes to 
different levels of influence of the ANS on maintenance of the respective conditions. It 
should also be noted in this discussion that HF can alternatively be caused by or associated 
with several other conditions, so while a prolonged condition affecting the cardiovascular 
system similar to CAD, it’s root cause and the body’s response is likely to differ from 
CAD. 
 
The MI cohort, similarly to CAD, had a significant increase in cell size compared to 
controls with no cardiac pathology, but there was not as high a degree of clustering as noted 
in CAD and HF. Perhaps an increase in stellate ganglion neuronal size is a first response 
of the ANS in an urgent event of the cardiovascular system, while clustering of the neurons 
may be more a feature of prolonged disease where increased activity is needed longer, 
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requiring nerve sprouting to keep up with the demand. In order to confirm this hypothesis, 
further research would have to be completed analyzing the sympathetic activity in patient’s 
representative of each of these disease cohorts over the course of the condition. This is an 
area that needs to be looked at more closely to gain a better understanding between the 
relationship of these disease courses/conditions, and how the stellate ganglia either induces 
these pathological conditions or histologically changes as a result of the cardiovascular 
pathology. 
 
We also investigated whether there was an association between the side of the body 
affected by the pathological process and which ganglion was more greatly affected. The 
heat map analysis showed some minor differences in neuronal clustering between 
ipsilateral and contralateral sides, but no consistent pattern was evident. Previous research 
has shown that the right and left stellate ganglia innervate the heart differently.  
Specifically, the right will innervate the anterior region of the ventricles and the left will 
innervate the posterior portions of the ventricles.36 However, a similar left-right pattern to 
the histopathology of the stellate ganglia was not found to be associated with any of the 
cardiovascular conditions we studied. This supports the idea presented previously that 
remodeling in both ganglia involves some form of cross-talk between the two ganglia 
through mixed fibers or a systemic release of neurotropic agents.1 Further research into this 
area is important to gain a better understanding of the way the stellate ganglia remodel 





Primarily, this study was limited to looking at remodeling in the ANS associated with 
cardiovascular pathology postmortem, without any analysis of activity during the subjects’ 
lives. Although details regarding existing cardiovascular conditions were known for all 
subjects in this study, a complete medical history for each subject was not available. It is 
possible that some subjects had other unknown comorbidities that contributed to the 
histopathological changes we observed. Specifically, one of the subjects displaying very 
little to no cardiac pathology had neurons whose size were similar to those subjects with 
cardiac pathology present (approximately 100 pixels larger than the other two control 
subjects). This vast difference in neuronal size from other control subjects certainly could 
have been due to an unknown comorbidity. In addition, the sample sizes in this study were 
small, especially with regards to the MI cohort, most likely due in part to the invasiveness 
of the ganglion excision. Lastly, since this was a cadaveric study, we did not have any 




Overall, this study showed that cardiovascular disease is associated with histopathological 
evidence of stellate ganglion remodeling and that the magnitude and characteristics of these 
histological changes are different among each cardiovascular condition studied. Previous 
work has proven that the ANS plays a large role in regulating heart function, which is 
anatomically justified, as the two systems are very much interconnected. The 
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histopathological changes in the stellate ganglia observed in this study are consistent with 
the idea that the ANS and cardiovascular system adapt and change reciprocally, based on 
the body’s needs. Given that connection, there could be further therapeutic investigation 
into manipulating sympathetic influence as a way to treat cardiovascular disease. However, 
the debate remains whether these changes are causative of the issues seen in these 
cardiovascular diseases and/or occur as a consequence of them. Further studies of the 
histopathological and physiological changes that occur with these cardiovascular 
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